Cargando…

Incidence and risk factors for intravenous immunoglobulin‐related hemolysis: A systematic review of clinical trial and real‐world populations

BACKGROUND: Severe hemolysis rarely occurs in patients receiving intravenous immunoglobulin (IVIG) therapy. A systematic review was performed to assess the incidence of IVIG‐related hemolysis and the impact of patient and product risk factors. STUDY DESIGN AND METHODS: A systematic literature search...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cuesta, Hillary, El Menyawi, Ibrahim, Hubsch, Alphonse, Hoefferer, Liane, Mielke, Orell, Gabriel, Susie, Shebl, Amgad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9545798/ https://www.ncbi.nlm.nih.gov/pubmed/35916266 http://dx.doi.org/10.1111/trf.17028

Ejemplares similares

Isoagglutinin reduction in intravenous immunoglobulin (IgPro10, Privigen) by specific immunoaffinity chromatography reduces its reporting rates of hemolytic reactions: an analysis of spontaneous adverse event reports
por: Shebl, Amgad, et al.
Publicado: (2020)

Anti‐A/B isoagglutinin reduction in an intravenous immunoglobulin product and risk of hemolytic anemia: a hospital‐based cohort study
por: Wallenhorst, Christopher, et al.
Publicado: (2020)

Impact of screening and exclusion of high anti‐A titer donors on the risk of hemolytic anemia with intravenous immunoglobulin treatment: A hospital‐based cohort study in the US
por: Martinez, Carlos, et al.
Publicado: (2017)

Reduction of Isoagglutinin in Intravenous Immunoglobulin (IVIG) Using Blood Group A- and B-Specific Immunoaffinity Chromatography: Industry-Scale Assessment
por: Gerber, Simon, et al.
Publicado: (2016)

Hemolysis From Intravenous Immunoglobulin in Obese Patients With Kawasaki Disease
por: Van Anh, Khanh-Van Y., et al.
Publicado: (2020)

Restabilization treatment after intravenous immunoglobulin withdrawal in chronic inflammatory demyelinating polyneuropathy: Results from the pre‐randomization phase of the Polyneuropathy And Treatment with Hizentra study
por: Mielke, Orell, et al.
Publicado: (2019)

Hemolysis induced cross-matching difficulty with intravenous immunoglobulin: a case report
por: Sharma, Achyut, et al.
Publicado: (2018)

Clinical Experience With an L-Proline–Stabilized 10 % Intravenous Immunoglobulin (Privigen®): Real-Life Effectiveness and Tolerability
por: Dorsey, Morna J., et al.
Publicado: (2014)

Isoagglutinin‐reduced immunoglobulin retains efficacy in mouse models of immune thrombocytopenia and rheumatoid arthritis and is less likely to cause intravenous immunoglobulin–associated hemolysis
por: Cen, Selena Y., et al.
Publicado: (2019)

Fetal intraperitoneal injection of immunoglobulin diminishes alloimmune hemolysis
por: Matsuda, H, et al.
Publicado: (2011)

Quantitative Evidence of Wear-Off Effect at the End of the Intravenous IgG (IVIG) Dosing Cycle in Primary Immunodeficiency
por: Rojavin, Mikhail A., et al.
Publicado: (2016)

Intravenous Immunoglobulin Treatment in Kawasaki Disease Decreases the Incidence of Myopia
por: Yu, Hun-Ju, et al.
Publicado: (2021)

Efficacy and safety of Privigen® in patients with chronic inflammatory demyelinating polyneuropathy: results of a prospective, single-arm, open-label Phase III study (the PRIMA study)
por: Léger, Jean-Marc, et al.
Publicado: (2013)

INTRAVENOUS IMMUNOGLOBULIN IN DERMATOLOGY
por: Dhar, Sandipan
Publicado: (2009)

Prognostic value of the hemolysis index in patients with significant hemolysis
por: Cortés, Diego O, et al.
Publicado: (2015)

Critical review and meta-analysis of spurious hemolysis in blood samples collected from intravenous catheters
por: Lippi, Giuseppe, et al.
Publicado: (2013)

Post-artesunate delayed hemolysis after treatment of malaria with intravenous artesunate: A case study
por: Foster, Abigail
Publicado: (2022)

MECHANISM OF HEMOLYSIS BY COMPLEMENT : I. COMPLEMENT FIXATION AS AN ESSENTIAL PRELIMINARY TO HEMOLYSIS.
por: Eagle, Harry, et al.
Publicado: (1929)

Intravenous Immunoglobulin in the Management of Lupus Nephritis
por: Wenderfer, Scott E., et al.
Publicado: (2012)

Pemphigoid gestationis and intravenous immunoglobulin therapy()
por: Yang, Anes, et al.
Publicado: (2018)

Intravenous Immunoglobulin for Overwhelming Postsplenectomy Infection
por: Nakamura, Kensuke, et al.
Publicado: (2021)

Intravenous Immunoglobulin: Revisited – My Experience
por: Vaishampayan, Sanjeev S., et al.
Publicado: (2021)

Intravenous immunoglobulin for inflammatory demyelinating polyneuropathy
por: Talaei, M., et al.
Publicado: (2021)

Intravenous immunoglobulin for the treatment of Kawasaki disease
por: Broderick, Cathryn, et al.
Publicado: (2023)

High incidence of adrenal suppression in children with Kawasaki disease treated with intravenous immunoglobulin plus prednisolone
por: Goto, Masahiro, et al.
Publicado: (2015)

Oxidative Hemolysis of Erythrocytes Induced by Various Vitamins
por: Ibrahim, I. H., et al.
Publicado: (2006)

HEMOLYSIS OF CHICKEN BLOOD
por: Shattuck, G. Edgar
Publicado: (1928)

THE MECHANISM OF THE INHIBITION OF HEMOLYSIS
por: Ponder, Eric
Publicado: (1943)

Sitagliptin-induced hemolysis
por: Bekur, Ragini, et al.
Publicado: (2010)

Ceftriaxone-induced hemolysis
por: Guleria, Vivek S., et al.
Publicado: (2013)

Hemolysis During Hemodialysis
por: Sam, Ramin, et al.
Publicado: (2008)

A simple method to monitor hemolysis in real time
por: Van Buren, Tyler, et al.
Publicado: (2020)

Analysis of relapse by inflammatory Rasch‐built overall disability scale status in the PATH study of subcutaneous immunoglobulin in chronic inflammatory demyelinating polyneuropathy
por: Merkies, Ingemar S. J., et al.
Publicado: (2022)

Impact of Early Treatment With High-Dose Intravenous Immunoglobulin on Incidence of Kawasaki Disease Complications in Iranian Children
por: Karimi Yazdi, Alireza, et al.
Publicado: (2021)

Efficacy of Glucocorticoid plus Intravenous Immunoglobulin in Children with Immunoglobulin-Insensitive Kawasaki Disease
por: Ma, Yongmei, et al.
Publicado: (2022)

Cytomegalovirus-Induced Coombs-Positive Hemolysis or Drug-Induced Hemolysis in an Immunocompetent Young Adult
por: Yacoub, Mirna S, et al.
Publicado: (2022)

Intravenous Immunoglobulin Treatment in Multifocal Motor Neuropathy
por: van der Pol, W.-Ludo, et al.
Publicado: (2010)

Prioritization of Evidence-Based Indications for Intravenous Immunoglobulin
por: Orange, Jordan S., et al.
Publicado: (2013)

Intravenous immunoglobulin and Alzheimer’s disease: what now?
por: Loeffler, David A
Publicado: (2013)

541 Intravenous Immunoglobulin in Leukocyte Adhesion Deficiency
por: Oropeza, Said Arablin, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_s2edaph92g4jdb1a3n3mvo6d2i